// App-Quantinova.ai

OP0190 : UNDERSTANDING CURRENT PRESCRIPTION DRUG TREATMENT PARADIGMS FOR PATIENTS WITH OSTEOARTHRITIS IN EUROPE

Researchers

Presenter

  • P. G. Conaghan

Principal Investigators

  • L. Abraham

  • P. Graham-Clarke

  • L. Viktrup

  • J. C. Cappelleri

  • C. Beck

  • A. G. Bushmakin

  • N. Hatchell

  • E. Clayton

  • J. Jackson

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Pfizer Limited, Surrey, United Kingdom

  • Eli Lilly and Co, Sydney, Australia

  • Eli Lilly and Company, Indianapolis, United States of America

  • Pfizer, Inc, Groton, CT, United States of America

  • Adelphi Real World, Bollington, United Kingdom

Locations

  • United Kingdom

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved